Biotech Firms See 2004 Valuations to Continue Rising
Biotech: Many Look to Copy Biogen Idec Success


Investors' renewed interest in biotech stocks, a spate of product approvals, and a more efficient Food and Drug Administration have lifted the expectations of San Diego's industry leaders for the coming year...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99